Feasibility of Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a pilot study.
Not Applicable
- Conditions
- corticosteroid-refractory graft-versus-host disease
- Registration Number
- JPRN-UMIN000021349
- Lead Sponsor
- Tohoku University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 2
Inclusion Criteria
Not provided
Exclusion Criteria
1) with active infection 2) w/o informed consent 3) CCr<10 ml/min
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method response rete of GVHD adverse effect
- Secondary Outcome Measures
Name Time Method